Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

montelukast 4 MG Chewable Tablet [Singulair]

Known as: MONTELUKAST SODIUM 4 mg ORAL TABLET, CHEWABLE [SINGULAIR], Singulair 4 MG (montelukast sodium 4.2 MG) Chewable Tablet, Singulair 4 MG Chewable Tablet 
National Institutes of Health

Related topics

Related topics

12 relations
AspartameChewable TabletCroscarmellose SodiumMagnesium stearate
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Bioequivalence Study of Two 10 mg Montelukast Immediate-ReleaseTablets Formulations: A Randomized, Single-Dose, Open-Label, TwoPeriods, Crossover Study
tablets in twenty-four healthy volunteers. The Test product was Montelukast* manufactured by Tecnoquimicas S.A. (Jamundi… Expand
2013
2013
Troubles psychiatriques associés au montélukast : données de la base nationale de pharmacovigilance
Montelukast (Singulair(®)) has been the subject of post-marketing warnings about psychiatric events occurring that had not been… Expand
Review
2011
Review
2011
Status of protein engineering for biocatalysts: how to design an industrially useful biocatalyst.
Recent advances in the development of both experimental and computational protein engineering tools have enabled a number of… Expand
2010
2010
Montelucast (singulair®) Affects Bronchial And Nasal Reactivity Induced By Allergen Challenge
2008
2008
Le Montelukast (Singulair ® ) ne protège pas contre les lésions alvéolaires induites par l'hypéroxie chez le raton
Journal de Gynecologie Obstetrique et Biologie de la Reproduction - Vol. 31 - N° 2 - p. 210 
2007
2007
A Single-Center, Double Masked, Randomized, Placebo Controlled Study to Evaluate the Efficacy of Multiple Doses of 10 mg Montelukast Sodium (Singulair®) on the Signs and Symptoms of Allergic…
Review
2005
Review
2005
Leukotriene receptor antagonists - an update
  • Drug and therapeutics bulletin
  • 2005
    • Corpus ID: 32907443
Montelukast (Singulair - MSD) and zafirlukast (Accolate - AstraZeneca) are oral leukotriene receptor antagonists, licensed for… Expand
2004
2004
Urticaires paradoxalement aggravées par les antihistaminiques H1
Resume Introduction Les antihistaminiques H1 (anti-H1) sont le traitement de reference de l’urticaire chronique. Nous rapportons… Expand
2002
2002
Montelukast (Singulair®) bringt bei chronischen Asthmatikern mit ausgebauter Therapie keinen zusätzlichen Behandlungserfolg
2000
2000
Leukotrienes Antagonist - Montelukast (Singulair®) Asthma 治療的新藥物
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE